Top compounds associated with response to YME1L1

Feature Type	Compound	Dataset	Tissue	Stat	Standardized Coefficient	Nominal ANOVA p-value
mRNA	selumetinib:navitoclax (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.16	2e-05
mRNA	necrosulfonamide	CTRPv2	pan-cancer	AAC	-0.16	5e-05
mRNA	navitoclax:PLX-4032 (1:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.14	5e-05
mRNA	Parthenolide	CTRPv2	pan-cancer	AAC	-0.15	0.0001
mRNA	NVP-ADW742	CTRPv2	pan-cancer	AAC	-0.13	0.0002
mRNA	selumetinib:piperlongumine (8:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.13	0.0002
mRNA	tretinoin:navitoclax (4:1 mol/mol)	CTRPv2	pan-cancer	AAC	-0.13	0.0002
mRNA	Talazoparib	GDSC1000	pan-cancer	AAC	0.12	0.0004
mRNA	TW 37	GDSC1000	pan-cancer	AAC	0.12	0.0004
mRNA	Cerulenin	CTRPv2	pan-cancer	AAC	-0.12	0.0005

Download CSV